【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Market definition
1.3. Information procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources & third-party perspectives
1.3.4. Primary research
1.4. Information analysis
1.4.1. Data analysis models
1.5. Market formulation & data visualization
1.6. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Global Clinical Laboratory Tests Market Variables, Trends & Scope
3.1. Clinical Laboratory Tests Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Cost Structure Analysis
3.4. Reimbursement Framework
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.1.1. Rising geriatric population base
3.5.1.2. Growing prevalence of target diseases
3.5.1.3. Introduction of innovative solutions
3.5.1.4. Rising demand for early disease detection
3.5.2. Market Restraint Analysis
3.5.2.1. Presence of ambiguous regulatory framework
3.6. Clinical Laboratory Tests Market Analysis Tools
3.6.1. Industry Analysis – Porter’s
3.6.1.1. Supplier Power: Moderate due to large number of diagnostic test manufacturers
3.6.1.2. Buyer Power: Moderate due to presence of players entering into long-term contract
3.6.1.3. Substitution Threat: Low due to no/less external substitutes
3.6.1.4. Threat from new entrant: Moderate due to brand recognition of the existing players
3.6.1.5. Competitive rivalry: High due to increasing mergers & acquisitions by major players
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Environmental Landscape
3.7.3. Social Landscape
3.7.4. Technology Landscape
3.7.5. Legal Landscape
3.8. Major Deals & Strategic Alliances Analysis
3.8.1. Joint Ventures
3.8.2. Mergers & Acquisitions
3.8.3. Licensing & Partnership
3.8.4. Technology Collaborations
3.8.5. Strategic Divestments
Chapter 4. Clinical Laboratory Tests Market – Competitive Analysis
4.1. Recent developments & impact analysis, by key market participants
4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3. Public Companies
4.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
4.3.2. Company Market Share/Ranking, by region
4.3.3. Competitive Dashboard Analysis
4.3.4. Market Differentiators
4.3.5. Synergy Analysis: Major Deals & Strategic Alliances
4.4. Private Companies
4.4.1. List of key emerging companies
4.4.2. Regional network map
4.4.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
Chapter 5. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Type market share analysis, 2018 & 2026
5.3. Type Dashboard
5.4. Global Clinical Laboratory Tests Market, by Type, 2013 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2013 to 2026 for the following,
5.5.1. Complete blood count
5.5.1.1. Complete blood count market, 2014 – 2026 (USD Billion)
5.5.2. HGB/HCT testing
5.5.2.1. HGB/HCT testing market, 2014 – 2026 (USD Billion)
5.5.3. Basic metabolic panel testing
5.5.3.1. Basic metabolic panel market, 2014 – 2026 (USD Billion)
5.5.4. BUN creatinine testing
5.5.4.1. BUN creatinine testing market, 2014 – 2026 (USD Billion)
5.5.5. Electrolytes testing
5.5.5.1. Electrolytes testing market, 2014 – 2026 (USD Billion)
5.5.6. HbA1c testing
5.5.6.1. HbA1c testing market, 2014 – 2026 (USD Billion)
5.5.7. Comprehensive metabolic panel testing
5.5.7.1. Comprehensive metabolic panel testing market, 2014 – 2026 (USD Billion)
5.5.8. Liver panel testing
5.5.8.1. Liver panel testing market, 2014 – 2026 (USD Billion)
5.5.8.2. Hepatitis
5.5.8.2.1. Hepatitis market, 2014 – 2026 (USD Billion)
5.5.8.3. Bile duct obstruction
5.5.8.3.1. Bile duct obstruction market, 2014 – 2026 (USD Billion)
5.5.8.4. Liver Cirrhosis
5.5.8.4.1. Liver Cirrhosis market, 2014 – 2026 (USD Billion)
5.5.8.5. Liver Cancer
5.5.8.5.1. Liver Cancer market, 2014 – 2026 (USD Billion)
5.5.8.6. Bone disease
5.5.8.6.1. Bone disease market, 2014 – 2026 (USD Billion)
5.5.8.7. Autoimmune disorders
5.5.8.7.1. Autoimmune disorders market, 2014 – 2026 (USD Billion)
5.5.8.8. Others
5.5.8.8.1. Others market, 2014 – 2026 (USD Billion)
5.5.9. Renal panel testing
5.5.9.1. Renal panel testing market, 2014 – 2026 (USD Billion)
5.5.10. Lipid panel testing
5.5.10.1. Lipid panel testing market, 2014 – 2026 (USD Billion)
Chapter 6. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. End-use market share analysis, 2018 & 2026
6.3. End-use Dashboard
6.4. Global Clinical Laboratory Tests Market, by End-use, 2013 to 2026
6.5. Market Size & Forecasts and Trend Analyses, 2013 to 2026 for the following,
6.5.1. Central Laboratories
6.5.1.1. Central laboratories market, 2014 – 2026 (USD Billion)
6.5.1.2. Complete blood count
6.5.1.2.1. Complete blood count market, 2014 – 2026 (USD Billion)
6.5.1.3. HGB/HCT testing
6.5.1.3.1. HGB/HCT testing market, 2014 – 2026 (USD Billion)
6.5.1.4. Basic metabolic panel testing
6.5.1.4.1. Basic metabolic panel testing market, 2014 – 2026 (USD Billion)
6.5.1.5. BUN creatinine testing.
6.5.1.5.1. BUN creatinine testing. market, 2014 – 2026 (USD Billion)
6.5.1.6. Electrolytes testing
6.5.1.6.1. Electrolytes testing market, 2014 – 2026 (USD Billion)
6.5.1.7. HbA1c testing
6.5.1.7.1. HbA1c testing market, 2014 – 2026 (USD Billion)
6.5.1.8. Comprehensive metabolic panel testing
6.5.1.8.1. Comprehensive metabolic panel testing market, 2014 – 2026 (USD Billion)
6.5.1.9. Liver panel testing
6.5.1.9.1. Liver panel testing market, 2014 – 2026 (USD Billion)
6.5.1.10. Renal panel testing
6.5.1.10.1. Renal panel testing market, 2014 – 2026 (USD Billion)
6.5.1.11. Lipid panel testing
6.5.1.11.1. Lipid panel testing market, 2014 – 2026 (USD Billion)
6.5.2. Primary Clinics
6.5.2.1. Primary clinics market, 2014 – 2026 (USD Billion)
6.5.2.2. Complete blood count
6.5.2.3. Complete blood count market, 2014 – 2026 (USD Billion)
6.5.2.4. HGB/HCT testing
6.5.2.4.1. HGB/HCT testing market, 2014 – 2026 (USD Billion)
6.5.2.5. Basic metabolic panel testing
6.5.2.5.1. Basic metabolic panel testing market, 2014 – 2026 (USD Billion)
6.5.2.6. BUN creatinine testing
6.5.2.6.1. BUN creatinine testing market, 2014 – 2026 (USD Billion)
6.5.2.7. Electrolytes testing
6.5.2.7.1. Electrolytes testing market, 2014 – 2026 (USD Billion)
6.5.2.8. HbA1c testing
6.5.2.8.1. HbA1c testing market, 2014 – 2026 (USD Billion)
6.5.2.9. Comprehensive metabolic panel testing
6.5.2.9.1. Comprehensive metabolic panel testing market, 2014 – 2026 (USD Billion)
6.5.2.10. Liver panel testing
6.5.2.10.1. Liver panel testing market, 2014 – 2026 (USD Billion)
6.5.2.11. Renal panel testing.
6.5.2.11.1. Renal panel testing. market, 2014 – 2026 (USD Billion)
6.5.2.12. Lipid panel testing
6.5.2.12.1. Lipid panel testing market, 2014 – 2026 (USD Billion)
Chapter 7. Clinical Laboratory Tests Market: Regional Estimates & Trend analysis, by type, end-use and end-use by type
7.1. Regional Market Snapshot
7.2. Regional Market Share and Leading Players, 2018
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East & Africa
7.4. Market Size, & Forecasts, and Trend Analysis, 2018 to 2026
7.4.1. North America
7.4.1.1. North America clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.1.1.1. U.S.
7.4.1.1.1.1. U.S. clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.1.1.2. Canada
7.4.1.1.2.1. Canada clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2. Europe
7.4.2.1. Europe clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.1. U.K.
7.4.2.1.1.1. U.K. clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.2. Germany
7.4.2.1.2.1. Germany clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.3. Spain
7.4.2.1.3.1. Spain clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.4. France
7.4.2.1.4.1. France clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.5. Italy
7.4.2.1.5.1. Italy clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.2.1.6. Russia
7.4.2.1.6.1. Russia clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3. Asia Pacific
7.4.3.1. Asia Pacific clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.1. China
7.4.3.1.1.1. China clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.2. Japan
7.4.3.1.2.1. Japan clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.3. India
7.4.3.1.3.1. India clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.4. South Korea
7.4.3.1.4.1. South Korea clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.5. Singapore
7.4.3.1.5.1. Singapore clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.3.1.6. Australia
7.4.3.1.6.1. Australia clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.4. Latin America
7.4.4.1. Latin America clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.4.1.1. Brazil
7.4.4.1.1.1. Brazil clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.4.1.2. Mexico
7.4.4.1.2.1. Mexico clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.4.1.3. Argentina
7.4.4.1.3.1. Argentina clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.5. Middle East Africa
7.4.5.1. MEA clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.5.1.1. South Africa
7.4.5.1.1.1. South Africa clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.5.1.2. Saudi Arabia
7.4.5.1.2.1. Saudi Arabia clinical laboratory tests market, 2014 – 2026 (USD Billion)
7.4.5.1.3. U.A.E.
7.4.5.1.3.1. U.A.E. clinical laboratory tests market, 2014 – 2026 (USD Billions)
Chapter 8. Company Profiles
8.1. Strategic Framework
8.1.1. Abbott
8.1.1.1. Company overview
8.1.1.2. Financial framework
8.1.1.3. Product benchmarking
8.1.1.4. Strategic initiatives
8.1.2. ARUP Laboratories
8.1.2.1. Company overview
8.1.2.2. Financial framework
8.1.2.3. Product benchmarking
8.1.2.4. Strategic initiatives
8.1.3. OPKO Health, Inc.
8.1.3.1. Company overview
8.1.3.2. Financial framework
8.1.3.3. Product benchmarking
8.1.3.4. Strategic initiatives
8.1.4. Bioscientia Institut für Medizinische Diagnostik GmbH
8.1.4.1. Company overview
8.1.4.2. Financial framework
8.1.4.3. Product benchmarking
8.1.4.4. Strategic initiatives
8.1.5. Charles River
8.1.5.1. Company overview
8.1.5.2. Financial framework
8.1.5.3. Product benchmarking
8.1.5.4. Strategic initiatives
8.1.6. NeoGenomics Laboratories, Inc.
8.1.6.1. Company overview
8.1.6.2. Financial framework
8.1.6.3. Product benchmarking
8.1.6.4. Strategic initiatives
8.1.7. Genoptix, Inc.
8.1.7.1. Company overview
8.1.7.2. Financial framework
8.1.7.3. Product benchmarking
8.1.7.4. Strategic initiatives
8.1.8. Healthscope
8.1.8.1. Company overview
8.1.8.2. Financial framework
8.1.8.3. Product benchmarking
8.1.8.4. Strategic initiatives
8.1.9. Labco
8.1.9.1. Company overview
8.1.9.2. Financial framework
8.1.9.3. Product benchmarking
8.1.9.4. Strategic initiatives
8.1.10. Laboratory Corporation of America Holdings (LabCorp)
8.1.10.1. Company overview
8.1.10.2. Financial framework
8.1.10.3. Product benchmarking
8.1.10.4. Strategic initiatives
8.1.11. QIAGEN
8.1.11.1. Company overview
8.1.11.2. Financial framework
8.1.11.3. Product benchmarking
8.1.11.4. Strategic initiatives
8.1.12. Quest Diagnostics
8.1.12.1. Company overview
8.1.12.2. Financial framework
8.1.12.3. Product benchmarking
8.1.12.4. Strategic initiatives
8.1.13. Siemens Healthcare GmbH
8.1.13.1. Company overview
8.1.13.2. Financial framework
8.1.13.3. Product benchmarking
8.1.13.4. Strategic initiatives
8.1.14. Sonic Healthcare
8.1.14.1. Company overview
8.1.14.2. Financial framework
8.1.14.3. Product benchmarking
8.1.14.4. Strategic initiatives
8.1.15. Fresenius Medical Care Holdings, Inc.
8.1.15.1. Company overview
8.1.15.2. Financial framework
8.1.15.3. Product benchmarking
8.1.15.4. Strategic initiatives
8.1.16. Merck KgaA
8.1.16.1. Company overview
8.1.16.2. Financial framework
8.1.16.3. Product benchmarking
8.1.16.4. Strategic initiatives
8.1.17. Tulip Diagnostics (P) Ltd.
8.1.17.1. Company overview
8.1.17.2. Financial framework
8.1.17.3. Product benchmarking
8.1.17.4. Strategic initiatives
8.1.18. Biosino Bio-technology and Science Inc
8.1.18.1. Company overview
8.1.18.2. Financial framework
8.1.18.3. Product benchmarking
8.1.18.4. Strategic initiatives
【レポート販売概要】
■ タイトル：臨床検査試験の世界市場：種類別（CBC、HGB/HCT、BMP、HbA1cテスト、電解質検査、肝パネル）、最終用途別（プライマリークリニック、セントラルラボ）、セグメント予測■ 英文：Clinical Laboratory Tests Market Analysis Report By Type (CBC, HGB/HCT, BMP, HbA1c Testing, Electrolyte Testing, Liver Panel), By End Use (Primary Clinics, Central Labs), And Segment Forecasts, 2019 - 2026
■ 発行日：2019年2月28日
■ 調査会社：Grand View Research
■ 商品コード：GVW903049
■ 調査対象地域：グローバル
- オーストラリアの食品安全検査市場The Australian food safety testing market is gaining growing level of importance in the country owing to continual increase in number of food-born disease outbreaks, increasingly stringent regulations on food safety, growing level of trade between Australia and other countries, sustained number of food recalls, among others. Rapid technologies dominate the Australian food safety testing market owi …
- 経肺薬剤送達システムの世界市場：計量投与用吸入器（MDI）、ドライパウダー吸入器（DPI）、ネブライザーAbout Pulmonary Drug Delivery Systems Pulmonary delivery of drugs leads to the deposition of drugs in the lungs and subsequent local or systemic therapeutic activity. The pulmonary route of administration for the non-invasive delivery of drugs is mostly preferred because of the large surface area for absorption, high blood circulation, and high permeability rate. Pulmonary drug delivery offers var …
- 世界の電子料金収受（ETC）システム市場分析及び予測（2013 – 2020）※当レポートは電子料金収受（ETC）システム市場の成長要因、主要イシュー、バリューチェーン、市場分析、競争環境、関連企業概要、並びにAvi、Avc、Ves商品別、技術別、応用分野別、地域別市場予測をまとめました。 Electronic Toll Collection system is mainly installed for the ease of transportation. In this system, tolls are collected with the help of electronic equipment installed on the roadside and without reducing the speed of the vehicle or stopping it. An ETC system consists of four segments named …
- 血液腫瘍検査の世界市場予測（～2024年）“Hemato oncology testing market to register a CAGR of 14.8% from 2019 to 2024” The hemato oncology testing market is projected to reach USD 4.0 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 14.8% during the forecast period. Growth in this market is mainly driven by the rising incidences & prevalence of leukemia, increasing collaborations for developing new assay kits, and the growing …
- クラウドAPIの世界市場：PaaS API、SaaS API、IaaS API、クロスプラットフォームAPICloud API operates as a middleware between systems or applications to ensure communication between these applications efficiently. The APIs are an intermediator that serves as an interface between different software applications and end users. This allows APIs to automatically use programming code to grant access to information and/or functionality between software, without having the developers t …
- グアーガム（Guar Gum）の世界市場：食用、薬用、産業用Guar gum is a natural gum extracted from guar seed. It has high natural viscosity, can be rapidly hydrated, and is freeze-thaw stable. The guar gum market has been segmented into different grades, various functions & applications of food grade guar gum, and regions. Different grades of guar gum are manufactured according to their industrial applications. The growing demand from various industrial …
- 家庭用AVケーブルの世界市場：HDMI、RCA、DVI、VGAThe global AV cables for residential market size was valued at $273.0 million in 2018, and is projected to reach $502.1 million by 2026, growing at a CAGR of 7.7% from 2019 to 2026. AV cables are the connecting components, which are used in multimedia devices for communication of audio and video signals. The cables either provide electrical, optical, or digital modes of transfer. Most of these cab …
- レーダーシステム及び技術の世界市場2016-2020About Radar Systems and Technology Since World War II, the defense forces are using different radar systems and technologies to detect and track insights and information. Radars determine range, angle, and velocity of an object. They are also used to map and locate weather conditions for the army, air force, and naval operations. Receivers and transmitters are vital components of a radar system si …
- ホットプレートスターラーの世界市場2017-2021About Hot Plate StirrerHot plate stirrer is a portable equipment that works on the same principle of regular magnetic stirrers, but integrates a heating component or coil on the platform or board. This allows the device to maintain the sample at the required temperature while stirring. This equipment features uniform heating and rough construction to meet the rigorous laboratory necessities. Techn …
- 海上クレーンの世界市場About Marine CraneMarine cranes are defined as the pedestal-mounted elevating and rotating lifting machinery used to transport materials or personnel to and from the marine vessels. Technavio’s analysts forecast the global marine crane market to grow at a CAGR of 4.62% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the globa …
- 民間航空産業におけるヘッドアップディスプレイ（HUD）市場About HUD An HUD is a display indicator that displays the key flight information onto a transparent screen positioned in front of a pilot's line of sight. HUD finds its applications in the automotive and aviation sectors. It helps increase the situational awareness and enhances safety margins in these sectors. The following are the primary components of an HUD: combiner, projector unit, display pa …
- 商用航空機向けビデオ監視システムの世界市場：操縦室ドア監視システム、客室監視システム、カメラThe commercial aircraft video surveillance systems market is estimated to be $127.13 million in 2014 and is expected to register a CAGR of 5.35% to reach $173.83 million by 2020. The report provides a market analysis of the commercial aircraft video surveillance systems market over the next six years. It contains the analysis of drivers, challenges, restraints, and burning issues that impact the i …
- GDF Suez Acquires West Coast Energy：M&Aディール分析GDF Suez Acquires West Coast Energy - Deal Analysis from GlobalData Summary Leading French multinational electric utility company GDF Suez SA (GDF Suez) acquired UK based renewable energy project developer West Coast Energy Ltd (WCE). The companies have already worked in partnership to deliver onshore wind energy projects in the UK since 2008. WCE has become part of the GDF Suez group and is respo …
- アスファルト添加剤の世界市場予測（～2026）：高分子改質剤、剥離防止・接着促進剤、乳化剤、化学修飾剤The asphalt additives market was valued at USD 2.79 Billion in 2015 and is projected to reach USD 5.45 Billion by 2026, at a CAGR of 6.4% between 2016 and 2026. This growth can be attributed to the development of the Asia-Pacific infrastructure market, recyclability of asphalt, development of warm mix asphalt, and increasing use of asphalt in roofing applications. Among types, the emulsifiers segm …
- 可変周波数駆動装置（VFD）の世界市場2015-2022According to Stratistics MRC, the Global Variable Frequency Drives (VFD) market is accounted for $18.12 billion in 2015 and is expected to reach $34.36 billion by 2022 growing at a CAGR of 9.5% during the forecast period. Increase in demand, price of the electricity, enlarging usage of variable frequency drives and following the best energy efficiency standards in manufacturing VFD are the major f …
